FTC Approves $5.4B Eli Lilly-Novartis Deal With Divestiture
The Federal Trade Commission on Monday cleared Eli Lilly & Co.'s $5.4 billion acquisition of Novartis AG's animal health unit on the condition that Eli Lilly shed Novartis' heartworm treatment product...To view the full article, register now.
Already a subscriber? Click here to view full article